Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

22.31
Delayed Data
As of Jun 24
 -1.52 / -6.38%
Today’s Change
16.75
Today|||52-Week Range
51.89
-32.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash80.9M8.9M30.7M21.7M
 
 
 
 
 
Short Term Investment Cash3.7M-1.7M21.8M-9.0M
 
 
 
 
 
Cash & Short Term Investments114.2M101.5M90.8M145.2M
 
 
 
 
 
 
ReceivablesReceivables2.9M1.6M1.7M15.7M
 
 
 
 
 
 
InventoriesInventories0.00--------
 
Current AssetsOther Current Assets604.0K1.6M15.5M9.7M
 
 
 
 
 
Current Assets117.7M104.7M108.0M170.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross5.1M5.5M5.9M10.2M
 
 
 
 
 
Depreciation-4.5M-4.3M-4.1M-4.3M
 
 
 
 
 
Other Assets2.2M0.000.000.00
 
 
Total Assets122.6M117.0M155.4M246.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.9M1.5M1.9M1.5M
 
 
 
 
 
Short Term Debt0.00--0.0069.0K
 
 
Accrued Expenses2.6M2.0M1.6M964.0K
 
 
 
 
 
Other Current Liabilities2.6M2.0M1.6M2.3M
 
 
 
 
 
Other Liabilities5.7M4.5M4.7M6.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.000.00692.0K
 
 
Deferred Taxes0.000.00-4.2M-4.6M
 
 
 
Other Liabilities2.5M1.9M1.7M1.9M
 
 
 
 
 
Total Liabilities8.2M6.5M6.6M9.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.00202.0K0.00
 
 
Common Equity114.4M110.5M148.7M236.2M
 
 
 
 
 
Total Shareholder Equity114.4M110.5M148.9M236.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding16.8M17.9M18.6M18.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.